ESR1 and breast cancer: Chen et al. [47] demonstrated that baicalin suppressed luminal breast cancer (ZR-75-1) growth by downregulating ESR1 but promoted triple-negative breast cancer (MDA-MB-231) growth by upregulating PROCR.